Publication | Open Access
NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOR phosphorylation
26
Citations
33
References
2015
Year
Taken together, we suggest that NVP-BEZ235 inhibits gefitinib-resistant tumor growth by downregulating PI3K/AKT/mTOR phosphorylation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1